The DOI matches its Crossref record; 186 of the 186 references it cites were found in a registry or an index.
Molecular Mechanisms and Emerging Therapeutics for Osteoporosis
Open accessAbstract
Osteoporosis is the most common chronic metabolic bone disease. It has been estimated that more than 10 million people in the United States and 200 million men and women worldwide have osteoporosis. Given that the aging population is rapidly increasing in many countries, osteoporosis could become a global challenge with an impact on the quality of life of the affected individuals. Osteoporosis can be defined as a condition characterized by low bone density and increased risk of fractures due to the deterioration of the bone architecture. Thus, the major goal of treatment is to reduce the risk for fractures. There are several treatment options, mostly medications that can control disease progression in risk groups, such as postmenopausal women and elderly men. Recent studies on the basic molecular mechanisms and clinical implications of osteoporosis have identified novel therapeutic targets. Emerging therapies targeting novel disease mechanisms could provide powerful approaches for osteoporosis management in the future. Here, we review the etiology of osteoporosis and the molecular mechanism of bone remodeling, present current pharmacological options, and discuss emerging therapies targeting novel mechanisms, investigational treatments, and new promising therapeutic approaches.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Ishida, Y., & Kawai, S. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.05.019 · Cited by 131
RetractedOsteoclast differentiation and activation
Boyle, W. J., Simonet, W. S., & Lacey, D. L. (2003) · Nature · doi:10.1038/nature01658 · Cited by 6,670 · cited 4×
“OPG is a decoy receptor of RANKL that competitively binds to the trimer RANKL, preventing RANKL-induced osteoclast maturation and promoting osteoclast apoptosis [15,75].”
BackgroundInfluential(1994) · PubMed · Cited by 4,960
An estimate of the worldwide prevalence and disability associated with osteoporotic fractures
Johnell, O., & Kanis, J. A. (2006) · Osteoporosis International · doi:10.1007/s00198-006-0172-4 · Cited by 4,704
Neer, R. M., Arnaud, C. D., Zanchetta, J. R., Prince, R., Gaich, G. A., Reginster, J.-Y., Hodsman, A. B., Eriksen, E. F., Ish-Shalom, S., Genant, H. K., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105103441904 · Cited by 4,602
Clinician’s Guide to Prevention and Treatment of Osteoporosis
Cosman, F., de Beur, S. J., LeBoff, M. S., Lewiecki, E. M., Tanner, B., Randall, S., & Lindsay, R. (2014) · Osteoporosis International · doi:10.1007/s00198-014-2794-2 · Cited by 4,149 · cited 2×
“Fractures in the population affected by osteoporosis determine the quality of life, as they cause pain, impaired mobility, substantially reduce pulmonary function [12], affect the risk of infection, lead to changes in body image, psychosocial distress, social isolation, loss of independence, and eventually, determine…”
BackgroundBone Resorption by Osteoclasts
Teitelbaum, S. L. (2000) · Science · doi:10.1126/science.289.5484.1504 · Cited by 3,962
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
Cummings, S. R., Martin, J. S., McClung, M. R., Siris, E. S., Eastell, R., Reid, I. R., Delmas, P., Zoog, H. B., Austin, M., Wang, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0809493 · Cited by 3,489
Multi-omics approaches to disease
Hasin, Y., Seldin, M., & Lusis, A. (2017) · Genome Biology · doi:10.1186/s13059-017-1215-1 · Cited by 2,953
Compston, J. E., McClung, M. R., & Leslie, W. D. (2019) · The Lancet · doi:10.1016/s0140-6736(18)32112-3 · Cited by 2,449
Bonewald, L. F. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.320 · Cited by 2,287
An overview and management of osteoporosis
Sözen, T., Özışık, L., & Çalık Başaran, N. (2019) · European Journal of Rheumatology · doi:10.5152/eurjrheum.2016.048 · Cited by 2,262
Aptamers as targeted therapeutics: current potential and challenges
Zhou, J., & Rossi, J. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.199 · Cited by 2,221
Calcium plus Vitamin D Supplementation and the Risk of Fractures
Jackson, R. D., LaCroix, A. Z., Gass, M., Wallace, R. B., Robbins, J., Lewis, C. E., Bassford, T., Beresford, S. A. A., Black, H. R., Blanchette, P., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055218 · Cited by 1,883
Romosozumab Treatment in Postmenopausal Women with Osteoporosis
Cosman, F., Crittenden, D. B., Adachi, J. D., Binkley, N., Czerwinski, E., Ferrari, S., Hofbauer, L. C., Lau, E., Lewiecki, E. M., Miyauchi, A., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1607948 · Cited by 1,805
Wright, N. C., Looker, A. C., Saag, K. G., Curtis, J. R., Delzell, E. S., Randall, S., & Dawson-Hughes, B. (2014) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2269 · Cited by 1,801
Pathogenesis of osteoporosis: concepts, conflicts, and prospects
Raisz, L. G. (2005) · Journal of Clinical Investigation · doi:10.1172/jci27071 · Cited by 1,779 · cited 1×
“Thus, due to age-related hormonal changes, men and women have equal rates of bone loss by the age of 60 years and are at risk of developing osteoporosis [17,18].”
BackgroundWeinstein, R. S., Jilka, R. L., Parfitt, A. M., & Manolagas, S. C. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2799 · Cited by 1,753 · cited 1×
“Glucocorticoids enhance the differentiation and maturation of osteoclasts [23], while inhibiting osteoblastogenesis by promoting osteoblast and osteocyte apoptosis [24], resulting in increased bone resorption and decreased bone formation [25,26].”
BackgroundGenetic regulation of osteoclast development and function
Teitelbaum, S. L., & Ross, F. P. (2003) · Nature Reviews Genetics · doi:10.1038/nrg1122 · Cited by 1,701
Schuit, S. C. E., van der Klift, M., Weel, A. E. A. M., de Laet, C. E. D. H., Burger, H., Seeman, E., Hofman, A., Uitterlinden, A. G., van Leeuwen, J. P. T. M., & Pols, H. A. P. (2004) · Bone · doi:10.1016/j.bone.2003.10.001 · Cited by 1,651
Parfitt, A. M., Mathews, C. H., Villanueva, A. R., Kleerekoper, M., Frame, B., & Rao, D. S. (1983) · Journal of Clinical Investigation · doi:10.1172/jci111096 · Cited by 1,545
Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis
Saag, K. G., Petersen, J., Brandi, M. L., Karaplis, A. C., Lorentzon, M., Thomas, T., Maddox, J., Fan, M., Meisner, P. D., & Grauer, A. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1708322 · Cited by 1,544
Sanders, K. M., Stuart, A. L., Williamson, E. J., Simpson, J. A., Kotowicz, M. A., Young, D., & Nicholson, G. C. (2010) · JAMA · doi:10.1001/jama.2010.594 · Cited by 1,381
Risk of Fracture after Androgen Deprivation for Prostate Cancer
Shahinian, V. B., Kuo, Y.-F., Freeman, J. L., & Goodwin, J. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa041943 · Cited by 1,375
Alendronate for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis
Saag, K. G., Emkey, R., Schnitzer, T. J., Brown, J. P., Hawkins, F., Goemaere, S., Thamsborg, G., Liberman, U. A., Delmas, P. D., Malice, M.-P., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807303390502 · Cited by 1,258
Bianco, P., Cao, X., Frenette, P. S., Mao, J. J., Robey, P. G., Simmons, P. J., & Wang, C.-Y. (2013) · Nature Medicine · doi:10.1038/nm.3028 · Cited by 1,197
TGF-β1–induced migration of bone mesenchymal stem cells couples bone resorption with formation
Tang, Y., Wu, X., Lei, W., Pang, L., Wan, C., Shi, Z., Zhao, L., Nagy, T. R., Peng, X., Hu, J., et al. (2009) · Nature Medicine · doi:10.1038/nm.1979 · Cited by 1,165
Building strong bones: molecular regulation of the osteoblast lineage
Long, F. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3254 · Cited by 1,141
Bisphosphonates: The first 40years
Russell, R. G. G. (2011) · Bone · doi:10.1016/j.bone.2011.04.022 · Cited by 1,124
Excess mortality following hip fracture: a systematic epidemiological review
Abrahamsen, B., van Staa, T., Ariely, R., Olson, M., & Cooper, C. (2009) · Osteoporosis International · doi:10.1007/s00198-009-0920-3 · Cited by 1,079
The Osteocyte: An Endocrine Cell … and More
Dallas, S. L., Prideaux, M., & Bonewald, L. F. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1026 · Cited by 1,042
Kremen proteins are Dickkopf receptors that regulate Wnt/β-catenin signalling
Mao, B., Wu, W., Davidson, G., Marhold, J., Li, M., Mechler, B. M., Delius, H., Hoppe, D., Stannek, P., Walter, C., et al. (2002) · Nature · doi:10.1038/nature756 · Cited by 1,038
Estrogen Prevents Bone Loss via Estrogen Receptor α and Induction of Fas Ligand in Osteoclasts
Nakamura, T., Imai, Y., Matsumoto, T., Sato, S., Takeuchi, K., Igarashi, K., Harada, Y., Azuma, Y., Krust, A., Yamamoto, Y., et al. (2007) · Cell · doi:10.1016/j.cell.2007.07.025 · Cited by 1,013
Risk of Mortality Following Clinical Fractures
Cauley, J. A., Thompson, D. E., Ensrud, K. C., Scott, J. C., & Black, D. (2000) · Osteoporosis International · doi:10.1007/s001980070075 · Cited by 947
Miller, P. D., Hattersley, G., Riis, B. J., Williams, G. C., Lau, E., Russo, L. A., Alexandersen, P., Zerbini, C. A. F., Hu, M.-Y., Harris, A. G., et al. (2016) · JAMA · doi:10.1001/jama.2016.11136 · Cited by 875
Zebaze, R. M., Ghasem-Zadeh, A., Bohte, A., Iuliano-Burns, S., Mirams, M., Price, R. I., Mackie, E. J., & Seeman, E. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60320-0 · Cited by 865
Bolland, M. J., Grey, A., Avenell, A., Gamble, G. D., & Reid, I. R. (2011) · BMJ · doi:10.1136/bmj.d2040 · Cited by 851
Interim Report and Recommendations of the World Health Organization Task-Force for Osteoporosis
Genant, H. K., Cooper, C., Poor, G., Reid, I., Ehrlich, G., Kanis, J., Nordin, B. E. C., Barrett-Connor, E., Black, D., Bonjour, J.-P., et al. (1999) · Osteoporosis International · doi:10.1007/s001980050224 · Cited by 783
An atlas of genetic influences on osteoporosis in humans and mice
23andMe Research Team, Morris, J. A., Kemp, J. P., Youlten, S. E., Laurent, L., Logan, J. G., Chai, R. C., Vulpescu, N. A., Forgetta, V., Kleinman, A., et al. (2019) · Nature Genetics · doi:10.1038/s41588-018-0302-x · Cited by 773
Mechanisms of Bone Resorption in Periodontitis
Hienz, S. A., Paliwal, S., & Ivanovski, S. (2015) · Journal of Immunology Research · doi:10.1155/2015/615486 · Cited by 762
Osteoporosis: A Review of Treatment Options.
Tu, K. N., Lie, J. D., Wan, C. K. V., Cameron, M., Austel, A. G., Nguyen, J. K., Van, K., & Hyun, D. (2018) · PubMed · Cited by 735
Tumor Necrosis Factor-α Induces Differentiation of and Bone Resorption by Osteoclasts
Azuma, Y., Kaji, K., Katogi, R., Takeshita, S., & Kudo, A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.7.4858 · Cited by 731
Bench to bedside: elucidation of the OPG–RANK–RANKL pathway and the development of denosumab
Lacey, D. L., Boyle, W. J., Simonet, W. S., Kostenuik, P. J., Dougall, W. C., Sullivan, J. K., Martin, J. S., & Dansey, R. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3705 · Cited by 694
Osteoclast-derived activity in the coupling of bone formation to resorption
Martin, T. J., & Sims, N. A. (2005) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.12.004 · Cited by 659
Current Understanding of RANK Signaling in Osteoclast Differentiation and Maturation
Park, J. H., Lee, N. K., & Lee, S. Y. (2017) · Molecules and Cells · doi:10.14348/molcells.2017.0225 · Cited by 645
Osteoblast Differentiation at a Glance
Rutkovskiy, A., Stensløkken, K.-O., & Vaage, I. J. (2016) · Medical Science Monitor Basic Research · doi:10.12659/msmbr.901142 · Cited by 621
Osteoporosis in Men: An Endocrine Society Clinical Practice Guideline
Watts, N. B., Adler, R. A., Bilezikian, J. P., Drake, M. T., Eastell, R., Orwoll, E. S., & Finkelstein, J. S. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3045 · Cited by 611
Biology of the RANKL–RANK–OPG System in Immunity, Bone, and Beyond
Walsh, M. C., & Choi, Y. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00511 · Cited by 599
Reid, D. M., Hughes, R. A., Laan, R. F. J. M., Sacco-Gibson, N. A., Wenderoth, D. H., Adami, S., Eusebio, R. A., & Devogelaer, J.-P. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.6.1006 · Cited by 592
Buckley, L., Guyatt, G., Fink, H. A., Cannon, M., Grossman, J., Hansen, K. E., Humphrey, M. B., Lane, N. E., Magrey, M., Miller, M., et al. (2017) · Arthritis Care & Research · doi:10.1002/acr.23279 · Cited by 579
Peripheral cannabinoid receptor, CB2, regulates bone mass
Ofek, O., Karsak, M., Leclerc, N., Fogel, M., Frenkel, B., Wright, K., Tam, J., Attar-Namdar, M., Kram, V., Shohami, E., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504187103 · Cited by 536
Reid, D. M., Devogelaer, J.-P., Saag, K., Roux, C., Lau, C.-S., Reginster, J.-Y., Papanastasiou, P., Ferreira, A., Hartl, F., Fashola, T., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60250-6 · Cited by 527
Buckley, L., Guyatt, G., Fink, H. A., Cannon, M., Grossman, J., Hansen, K. E., Humphrey, M. B., Lane, N. E., Magrey, M., Miller, M., et al. (2017) · Arthritis & Rheumatology · doi:10.1002/art.40137 · Cited by 527
Xu, F., & Teitelbaum, S. L. (2013) · Bone Research · doi:10.4248/br201301003 · Cited by 523
PPAR-γ regulates osteoclastogenesis in mice
Wan, Y., Chong, L.-W., & Evans, R. M. (2007) · Nature Medicine · doi:10.1038/nm1672 · Cited by 517
Bischoff-Ferrari, H. A., Dawson-Hughes, B., Orav, E. J., Staehelin, H. B., Meyer, O. W., Theiler, R., Dick, W., Willett, W. C., & Egli, A. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.7148 · Cited by 511
Integration of BMP, Wnt, and notch signaling pathways in osteoblast differentiation
Lin, G. L., & Hankenson, K. D. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23287 · Cited by 510
Langdahl, B. L., Libanati, C., Crittenden, D. B., Bolognese, M. A., Brown, J. P., Daizadeh, N. S., Dokoupilova, E., Engelke, K., Finkelstein, J. S., Genant, H. K., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31613-6 · Cited by 497
Saag, K. G., Zanchetta, J. R., Devogelaer, J., Adler, R. A., Eastell, R., See, K., Krege, J. H., Krohn, K., & Warner, M. R. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24879 · Cited by 493
Review of Signaling Pathways Governing MSC Osteogenic and Adipogenic Differentiation
James, A. W. (2013) · Scientifica · doi:10.1155/2013/684736 · Cited by 493
Pathogenesis of glucocorticoid-induced osteoporosis and options for treatment
Chotiyarnwong, P., & McCloskey, E. V. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-0341-0 · Cited by 489
Glucocorticoid-induced osteoporosis: an update
Compston, J. (2018) · Endocrine · doi:10.1007/s12020-018-1588-2 · Cited by 471
The Aftermath of Hip Fracture: Discharge Placement, Functional Status Change, and Mortality
Bentler, S. E., Liu, L., Obrizan, M., Cook, E. A., Wright, K. B., Geweke, J. F., Chrischilles, E. A., Pavlik, C. E., Wallace, R. B., Ohsfeldt, R. L., et al. (2009) · American Journal of Epidemiology · doi:10.1093/aje/kwp266 · Cited by 470
Regulatory mechanisms in the pathways of cartilage and bone formation
de Crombrugghe, B., Lefebvre, V., & Nakashima, K. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00276-3 · Cited by 461
Sun, Y. V., & Hu, Y.-J. (2016) · Advances in Genetics · doi:10.1016/bs.adgen.2015.11.004 · Cited by 459
Growth factors for bone growth and repair: IGF, TGFβ and BMP
Linkhart, T. A., Mohan, S., & Baylink, D. J. (1996) · Bone · doi:10.1016/s8756-3282(96)00138-x · Cited by 440
Glucocorticoid-Induced Osteoporosis
Buckley, L., & Humphrey, M. B. (2018) · New England Journal of Medicine · doi:10.1056/nejmcp1800214 · Cited by 438
Advances in Regenerative Medicine and Tissue Engineering: Innovation and Transformation of Medicine
Dzobo, K., Thomford, N. E., Senthebane, D. A., Shipanga, H., Rowe, A., Dandara, C., Pillay, M., & Motaung, K. S. C. M. (2018) · Stem Cells International · doi:10.1155/2018/2495848 · Cited by 433
Transcriptional mechanisms in osteoblast differentiation and bone formation
Nakashima, K., & de Crombrugghe, B. (2003) · Trends in Genetics · doi:10.1016/s0168-9525(03)00176-8 · Cited by 432
Udagawa, N., Takahashi, N., Jimi, E., Matsuzaki, K., Tsurukai, T., Itoh, K., Nakagawa, N., Yasuda, H., Goto, M., Tsuda, E., et al. (1999) · Bone · doi:10.1016/s8756-3282(99)00210-0 · Cited by 412
Booth, S. L., Tucker, K. L., Chen, H., Hannan, M. T., Gagnon, D. R., Cupples, L. A., Wilson, P. W., Ordovas, J., Schaefer, E. J., Dawson-Hughes, B., et al. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.5.1201 · Cited by 406
Osteoclast-poor human osteopetrosis due to mutations in the gene encoding RANKL
Sobacchi, C., Frattini, A., Guerrini, M. M., Abinun, M., Pangrazio, A., Susani, L., Bredius, R., Mancini, G., Cant, A., Bishop, N., et al. (2007) · Nature Genetics · doi:10.1038/ng2076 · Cited by 389
Lasofoxifene in Postmenopausal Women with Osteoporosis
Cummings, S. R., Ensrud, K., Delmas, P. D., LaCroix, A. Z., Vukicevic, S., Reid, D. M., Goldstein, S., Sriram, U., Lee, A., Thompson, J., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0808692 · Cited by 387
Denosumab: mechanism of action and clinical outcomes
Hanley, D. A., Adachi, J. D., Bell, A., & Brown, V. (2012) · International Journal of Clinical Practice · doi:10.1111/ijcp.12022 · Cited by 377
LGR4 is a receptor for RANKL and negatively regulates osteoclast differentiation and bone resorption
Luo, J., Yang, Z., Ma, Y., Yue, Z., Lin, H., Qu, G., Huang, J., Dai, W., Li, C., Zheng, C., et al. (2016) · Nature Medicine · doi:10.1038/nm.4076 · Cited by 370
Hock, J. M., & Gera, I. (1992) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650070110 · Cited by 367
Role of Mesenchymal Stem Cells in Bone Regenerative Medicine: What Is the Evidence?
Oryan, A., Kamali, A., Moshiri, A., & Baghaban Eslaminejad, M. (2017) · Cells Tissues Organs · doi:10.1159/000469704 · Cited by 353
A road map for understanding molecular and genetic determinants of osteoporosis
Yang, T.-L., Shen, H., Liu, A., Dong, S.-S., Zhang, L., Deng, F.-Y., Zhao, Q., & Deng, H.-W. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0282-7 · Cited by 341
Bone loss caused by iron overload in a murine model: importance of oxidative stress
Tsay, J., Yang, Z., Ross, F. P., Cunningham-Rundles, S., Lin, H., Coleman, R., Mayer-Kuckuk, P., Doty, S. B., Grady, R. W., Giardina, P. J., et al. (2010) · Blood · doi:10.1182/blood-2009-12-260083 · Cited by 340
Prevalence of long-term oral glucocorticoid prescriptions in the UK over the past 20 years
Fardet, L., Petersen, I., & Nazareth, I. (2011) · Rheumatology · doi:10.1093/rheumatology/ker017 · Cited by 319
Knothe Tate, M. L., Adamson, J. R., Tami, A. E., & Bauer, T. W. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(03)00241-3 · Cited by 310
Papadimitropoulos, E., Wells, G., Shea, B., Gillespie, W., Weaver, B., Zytaruk, N., Cranney, A., Adachi, J., Tugwell, P., Josse, R., et al. (2002) · Endocrine Reviews · doi:10.1210/er.2001-8002 · Cited by 302
Hattersley, G., Dean, T., Corbin, B. A., Bahar, H., & Gardella, T. J. (2016) · Endocrinology · doi:10.1210/en.2015-1726 · Cited by 300
Mesenchymal Stem Cell Migration during Bone Formation and Bone Diseases Therapy
Su, P., Tian, Y., Yang, C., Ma, X., Wang, X., Pei, J., & Qian, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082343 · Cited by 269
Crandall, C. J., Newberry, S. J., Diamant, A., Lim, Y.-W., Gellad, W. F., Booth, M. J., Motala, A., & Shekelle, P. G. (2014) · Annals of Internal Medicine · doi:10.7326/m14-0317 · Cited by 254
Takeshita, S., Namba, N., Zhao, J. J., Jiang, Y., Genant, H. K., Silva, M. J., Brodt, M. D., Helgason, C. D., Kalesnikoff, J., Rauh, M. J., et al. (2002) · Nature Medicine · doi:10.1038/nm752 · Cited by 252
Akt Induces Osteoclast Differentiation through Regulating the GSK3β/NFATc1 Signaling Cascade
Moon, J. B., Kim, J. H., Kim, K., Youn, B. U., Ko, A., Lee, S. Y., & Kim, N. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1101254 · Cited by 252
PGC1β Mediates PPARγ Activation of Osteoclastogenesis and Rosiglitazone-Induced Bone Loss
Wei, W., Wang, X., Yang, M., Smith, L. C., Dechow, P. C., & Wan, Y. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.04.015 · Cited by 243
Osteoblasts in osteoporosis: Past, emerging, and future anabolic targets
Marie, P. J., & Kassem, M. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0132 · Cited by 234
Henriksen, K., Bollerslev, J., Everts, V., & Karsdal, M. A. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0006 · Cited by 230
Cannabinoid receptor type 2 gene is associated with human osteoporosis
Karsak, M., Cohen-Solal, M., Freudenberg, J., Ostertag, A., Morieux, C., Kornak, U., Essig, J., Erxlebe, E., Bab, I., Kubisch, C., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi370 · Cited by 219
Chen, H., Lee, M., Chen, C., Chuang, S., Chang, L., Ho, M., Hung, S., Fu, Y., Wang, Y., Wang, H., et al. (2012) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01335.x · Cited by 218
Lin, J. T., & Lane, J. M. (2004) · Clinical Orthopaedics and Related Research · doi:10.1097/01.blo.0000132404.30139.f2 · Cited by 218
Lin, J. T., & Lane, J. M. (2004) · PubMed · Cited by 217
Mortality rates after incident non-traumatic fractures in older men and women
Morin, S., Lix, L. M., Azimaee, M., Metge, C., Caetano, P., & Leslie, W. D. (2011) · Osteoporosis International · doi:10.1007/s00198-010-1480-2 · Cited by 212
Saag, K. G., Wagman, R. B., Geusens, P., Adachi, J. D., Messina, O. D., Emkey, R., Chapurlat, R., Wang, A., Pannacciulli, N., & Lems, W. F. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30075-5 · Cited by 209
Osteoporosis – a current view of pharmacological prevention and treatment
Crockett, J., & Das (2013) · Drug Design, Development and Therapy · doi:10.2147/dddt.s31504 · Cited by 206
Short-term and long-term effects of osteoporosis therapies
Reid, I. R. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.71 · Cited by 201
Signaling Networks that Control the Lineage Commitment and Differentiation of Bone Cells
Soltanoff, C. S., Yang, S., Chen, W., & Li, Y.-P. (2009) · Critical Reviews™ in Eukaryotic Gene Expression · doi:10.1615/critreveukargeneexpr.v19.i1.10 · Cited by 197
The Interplay between the Bone and the Immune System
Mori, G., D'Amelio, P., Faccio, R., & Brunetti, G. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/720504 · Cited by 193
RANKL/RANK/OPG system beyond bone remodeling: involvement in breast cancer and clinical perspectives
Infante, M., Fabi, A., Cognetti, F., Gorini, S., Caprio, M., & Fabbri, A. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-1001-2 · Cited by 180
Idris, A. I., Sophocleous, A., Landao-Bassonga, E., Canals, M., Milligan, G., Baker, D., van't Hof, R. J., & Ralston, S. H. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.07.006 · Cited by 179
M‐CSF, c‐Fms, and Signaling in Osteoclasts and their Precursors
ROSS, F. P. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1346.014 · Cited by 172
Balogh, E., Tolnai, E., Nagy, B., Nagy, B., Balla, G., Balla, J., & Jeney, V. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.06.003 · Cited by 172
Ioannidis, J. P., Ng, M. Y., Sham, P. C., Zintzaras, E., Lewis, C. M., Deng, H.-W., Econs, M. J., Karasik, D., Devoto, M., Kammerer, C. M., et al. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.060806 · Cited by 169
Yokota, K., Sato, K., Miyazaki, T., Kitaura, H., Kayama, H., Miyoshi, F., Araki, Y., Akiyama, Y., Takeda, K., & Mimura, T. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38218 · Cited by 166
Update on the Pharmacological Treatment of Alzheimers Disease
Massoud, F., & Gauthier, S. (2010) · Current Neuropharmacology · doi:10.2174/157015910790909520 · Cited by 163
Advances in Glucocorticoid-Induced Osteoporosis
den Uyl, D., Bultink, I. E. M., & Lems, W. F. (2011) · Current Rheumatology Reports · doi:10.1007/s11926-011-0173-y · Cited by 155
Binkley, N., Bolognese, M., Sidorowicz-Bialynicka, A., Vally, T., Trout, R., Miller, C., Buben, C. E., Gilligan, J. P., Krause, D. S., & for the Oral Calcitonin in Postmenopausal Osteoporosis (ORACAL) Investigators (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1602 · Cited by 149
Age-related Marrow Adipogenesis Is Linked to Increased Expression of RANKL
Takeshita, S., Fumoto, T., Naoe, Y., & Ikeda, K. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.547919 · Cited by 146
Crockett, J. C., Mellis, D. J., Scott, D. I., & Helfrich, M. H. (2011) · Osteoporosis International · doi:10.1007/s00198-010-1272-8 · Cited by 143
Intercellular Cross-Talk Among Bone Cells: New Factors and Pathways
Sims, N. A., & Walsh, N. C. (2012) · Current Osteoporosis Reports · doi:10.1007/s11914-012-0096-1 · Cited by 139
Molecular biology of bone remodelling.
Rucci, N. (2008) · PubMed · Cited by 138
Osteoporosis: the current status of mesenchymal stem cell-based therapy
Phetfong, J., Sanvoranart, T., Nartprayut, K., Nimsanor, N., Seenprachawong, K., Prachayasittikul, V., & Supokawej, A. (2016) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-016-0013-1 · Cited by 136
Wu, M., Chen, W., Lü, Y., Zhu, G., Hao, L., & Li, Y. (2017) · Nature Communications · doi:10.1038/ncomms13700 · Cited by 136
Wilson, S. G., Reed, P., Bansal, A. T., Chiano, M. N., Lindersson, M., Langdown, M., Prince, R. L., Thompson, D. B., Thompson, E., Bailey, M. E. S., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/345819 · Cited by 134
The RUNX2 Cistrome in Osteoblasts
Meyer, M. B., Benkusky, N. A., & Pike, J. W. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.552216 · Cited by 133
Signaling pathways governing osteoblast proliferation, differentiation and function.
Chau, J. F. L., Leong, W. F., & Li, B. (2009) · PubMed · doi:10.14670/hh-24.1593 · Cited by 132
Xiao, L., Sobue, T., Esliger, A., Kronenberg, M. S., Coffin, J. D., Doetschman, T., & Hurley, M. M. (2010) · Bone · doi:10.1016/j.bone.2010.05.021 · Cited by 127
Targeting sphingosine-1-phosphate lyase as an anabolic therapy for bone loss
Weske, S., Vaidya, M., Reese, A., Lipinski, K. V. W., Keul, P., Bayer, J. K., Fischer, J. W., Flögel, U., Nelsen, J., Epple, M., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0005-y · Cited by 127
Molecular-Based Treatment Strategies for Osteoporosis: A Literature Review
Ukon, Y., Makino, T., Kodama, J., Tsukazaki, H., Tateiwa, D., Yoshikawa, H., & Kaito, T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102557 · Cited by 122
Ugarte, F., Ryser, M., Thieme, S., Fierro, F. A., Navratiel, K., Bornhäuser, M., & Brenner, S. (2009) · Experimental Hematology · doi:10.1016/j.exphem.2009.03.007 · Cited by 118
Glucocorticoid-induced Osteoporosis
Whittier, X., & Saag, K. G. (2015) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2015.08.005 · Cited by 117
Trovas, G., Lyritis, G. P., Γαλανός, Α., Raptou, P. D., & Constantelou, E. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.3.521 · Cited by 115
Prospect of mesenchymal stem cells in therapy of osteoporosis: A review
Maleki, L. A., Dolati, S., Zandi, R., Fotouhi, A., Ahmadi, M., Aghebati, A., Nouri, M., Shakouri, S. K., & Yousefi, M. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27833 · Cited by 112
Dong, Z., Bonfil, R. D., Chinni, S. R., Deng, X., Filho, J. C. T., Bernardo, M. M., Vaishampayan, U. N., Che, M., Sloane, B. F., Sheng, S., et al. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62337-1 · Cited by 111
Calcitonin Therapy in Osteoporosis
Muñoz‐Torres, M., Alonso, G., & Raya, P. M. (2004) · Treatments in Endocrinology · doi:10.2165/00024677-200403020-00006 · Cited by 110
Exosomes: Mediators of bone diseases, protection, and therapeutics potential
Behera, J., & Tyagi, N. (2018) · Oncoscience · doi:10.18632/oncoscience.421 · Cited by 101
Prospect of Stem Cell Therapy and Regenerative Medicine in Osteoporosis
Arjmand, B., Sarvari, M., Alavi-Moghadam, S., Payab, M., Goodarzi, P., Gilany, K., Mehrdad, N., & Larijani, B. A. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00430 · Cited by 99
Zhao, R. (2012) · International Journal of Medical Sciences · doi:10.7150/ijms.5180 · Cited by 96
Bone loss. Epidemiology of bone loss.
Hunter, D. J., & Sambrook, P. N. (2000) · Arthritis Research · doi:10.1186/ar125 · Cited by 94
Long-term treatment of osteoporosis: safety and efficacy appraisal of denosumab
Anastasilakis, A. D., Toulis, K. A., Πολύζος, Σ., Anastasilakis, C. D., & Makras, P. (2012) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s24239 · Cited by 93
Editorial: Sclerostin and Wnt Signaling—The Pathway to Bone Strength
Ott, S. M. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2370 · Cited by 93
Pros and Cons of Denosumab Treatment for Osteoporosis and Implication for RANKL Aptamer Therapy
Zhang, N., Zhang, Z., Yu, Y., Zhuo, Z., Zhang, G., & Zhang, B. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00325 · Cited by 91
Muruganandan, S., Ionescu, A. M., & Sinal, C. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072277 · Cited by 90
Role of cannabinoids in the regulation of bone remodeling
Idris, A. I., & Ralston, S. H. (2012) · Frontiers in Endocrinology · doi:10.3389/fendo.2012.00136 · Cited by 89
Systematic review of the benefits and harms of calcitriol and alfacalcidol for fractures and falls
O’Donnell, S. C., Moher, D., Thomas, K., Hanley, D. A., & Cranney, A. (2008) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-008-0868-y · Cited by 89
Cong, Q., Jia, H., Li, P., Qiu, S., Yeh, J., Wang, Y., Zhang, Z., Ao, J., Li, B., & Liu, H. (2017) · Scientific Reports · doi:10.1038/srep45964 · Cited by 89
TAZ is required for the osteogenic and anti-adipogenic activities of kaempferol
Byun, M. R., Jeong, H., Bae, S. J., Kim, A. R., Hwang, E. S., & Hong, J. (2011) · Bone · doi:10.1016/j.bone.2011.10.035 · Cited by 86
Zhou, J., Ma, X., Wang, T., & Zhai, S. (2016) · Osteoporosis International · doi:10.1007/s00198-016-3654-z · Cited by 84
Osteoblast autophagy in glucocorticoid‐induced osteoporosis
Wang, L., Heckmann, B. L., Yang, X., & Long, H. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27335 · Cited by 84
New roles of osteoblasts involved in osteoclast differentiation
Yamashita, T., Takahashi, N., & Udagawa, N. (2012) · World Journal of Orthopedics · doi:10.5312/wjo.v3.i11.175 · Cited by 83
Stem cells in Osteoporosis: From Biology to New Therapeutic Approaches
Paspaliaris, V., & Kolios, G. C. (2019) · Stem Cells International · doi:10.1155/2019/1730978 · Cited by 82
Jung, H., Kim, D. O., Byun, J.-E., Kim, W. S., Kim, M. J., Song, H. Y., Kim, Y. K., Kang, D.-K., Park, Y.-J., Kim, T.-D., et al. (2016) · Nature Communications · doi:10.1038/ncomms13674 · Cited by 81
Self-citationYe, X., Zhang, P., Xue, S., et al. (2014) · Cytotherapy · doi:10.1016/j.jcyt.2014.07.009 · Cited by 79
Characterization of acetylcholinesterase expression and secretion during osteoblast differentiation
Inkson, C. A., Brabbs, A. C., Grewal, T. S., Skerry, T. M., & Genever, P. G. (2004) · Bone · doi:10.1016/j.bone.2004.05.026 · Cited by 74
Chemerin neutralization blocks hematopoietic stem cell osteoclastogenesis
Muruganandan, S., Dranse, H. J., Rourke, J. L., McMullen, N. M., & Sinal, C. J. (2013) · Stem Cells · doi:10.1002/stem.1450 · Cited by 73
Sisay, M., Mengistu, G., & Edessa, D. (2017) · OncoTargets and Therapy · doi:10.2147/ott.s135867 · Cited by 73
Muruganandan, S., Govindarajan, R., McMullen, N. M., & Sinal, C. J. (2016) · Stem Cells · doi:10.1002/stem.2520 · Cited by 64
Tamimi, I., Ojea, T., Sánchez-Siles, J.-M., Rojas, F., Martin, I., Gormaz, I., Perez, A., Dawid-Milner, M. S., Mendez, L., & Tamimi, F. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1616 · Cited by 63
Lin, T., Wang, C., Cai, X.-Z., Zhao, X., Shi, M.-M., Ying, Z., Yuan, F., Guo, C., & Yan, S.-G. (2012) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2011.02806.x · Cited by 62
Sclerostin Antibody Therapy for the Treatment of Osteoporosis: Clinical Prospects and Challenges
MacNabb, C., Patton, D., & Hayes, J. S. (2016) · Journal of Osteoporosis · doi:10.1155/2016/6217286 · Cited by 62
Phosphatidylinositol-3 kinase is involved in ruffled border formation in osteoclasts
Nakamura, I., Sasaki, T., Tanaka, S., Takahashi, N., Jimi, E., Kurokawa, T., Kita, Y., Ihara, S., Suda, T., & Fukui, Y. (1997) · Journal of Cellular Physiology · Cited by 60
Kawamata, A., Iihara, M., Okamoto, T., & Obara, T. (2008) · World Journal of Surgery · doi:10.1007/s00268-007-9394-7 · Cited by 58
von Keyserlingk, C., Hopkins, R. B., Anastasilakis, A. D., Toulis, K. A., Goeree, R. A., Tarride, J., & Xie, F. (2011) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2011.03.005 · Cited by 54
Liu, H., Chiou, J.-F., Wu, A. T. H., Tsai, C.-Y., Leu, J., Ting, L., Wang, M.-F., Chen, H., Lin, C.-T., Williams, D. F., et al. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.05.024 · Cited by 54
Lou, S., Lv, H., Yin, P., Li, Z., Tang, P., & Wang, Y. (2018) · Osteoporosis International · doi:10.1007/s00198-018-4790-4 · Cited by 54
PTEN regulation by the Akt/GSK-3β axis during RANKL signaling
Jang, H. D., Noh, J. Y., Shin, J. H., Lin, J., & Lee, S. Y. (2013) · Bone · doi:10.1016/j.bone.2013.02.005 · Cited by 53
Self-citationMi, B., Xiong, W., Xu, N., Guan, H., Fang, Z., Liao, H., Zhang, Y., Gao, B., Xiao, X., Fu, J., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-02491-9 · Cited by 52
Chu, C., Wei, S., Wang, Y., Wang, Y., Man, Y., & Qu, Y. (2018) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.36518 · Cited by 52
Tan, S., Zhang, B.-B., Zhu, X., Ao, P., Guo, H., Yi, W., & Zhou, G. (2014) · BioMed Research International · doi:10.1155/2014/814057 · Cited by 50
A Community-Based Hip Fracture Registry: Population, Methods, and Outcomes
Inacio, M. C. S., Weiss, J. M., Miric, A., Hunt, J. J., Zohman, G. L., & Paxton, E. W. (2015) · The Permanente Journal · doi:10.7812/tpp/14-231 · Cited by 49
Umbilical cord blood stem cells: clinical trials in non-hematological disorders
Ilić, D., Miere, C., & Lazic, E. (2012) · British Medical Bulletin · doi:10.1093/bmb/lds008 · Cited by 48
Yang, Y., Luo, X., Xie, X., Yan, F., Chen, G., Zhao, W., Jiang, Z., Fang, C., & Shen, J. (2016) · Climacteric · doi:10.3109/13697137.2015.1126576 · Cited by 47
Self-citationCB2 and TRPV1 receptors oppositely modulate in vitro human osteoblast activity
Rossi, F., Bellini, G., Tortora, C., Bernardo, M. E., Luongo, L., Conforti, A., Starc, N., Manzo, I., Nobili, B., Locatelli, F., et al. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.06.010 · Cited by 44
Nagaoka, M., Maeda, T., Moriwaki, S., Nomura, A., Kato, Y., Niida, S., Kruger, M. C., & Suzuki, K. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112795 · Cited by 42
Identification of a Role for the ARHGEF3 Gene in Postmenopausal Osteoporosis
Mullin, B. H., Prince, R. L., Dick, I. M., Hart, D. J., Spector, T. D., Dudbridge, F., & Wilson, S. G. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.04.016 · Cited by 41
Shiraki, M., Yamazaki, Y., Shiraki, Y., Hosoi, T., Tsugawa, N., & Okano, T. (2010) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-010-0167-2 · Cited by 41
Unveiling Mesenchymal Stromal Cells’ Organizing Function in Regeneration
Nimiritsky, P., Eremichev, R. Y., Alexandrushkina, N. A., Efimenko, A. Y., Va, T., & Макаревич, П. И. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20040823 · Cited by 41
Shiraki, M., & Itabashi, A. (2009) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-008-0034-6 · Cited by 40
Park, E., Kim, J., Kim, M.-C., Yeo, S., Kim, J. E., Park, S., Jo, M., Choi, C. W., Jin, H., Lee, S.-W., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112784 · Cited by 39
Using Osteoporosis Therapies in Combination
McClung, M. R. (2017) · Current Osteoporosis Reports · doi:10.1007/s11914-017-0376-x · Cited by 38
Goodarzi, P., Payab, M., Alavi-Moghadam, S., Larijani, B. A., Rahim, F., Bana, N., Sarvari, M., Adibi, H., Heravani, N. F., Hadavandkhani, M., et al. (2019) · Cell and Tissue Banking · doi:10.1007/s10561-019-09773-8 · Cited by 38
Bawa, S. (2010) · Journal of Osteoporosis · doi:10.4061/2010/891058 · Cited by 37
Glucocorticoid-induced osteoporosis: an osteoblastic disease.
Migliaccio, S., Brama, M., Fornari, R., Greco, E. A., Spera, G., & Malavolta, N. (2007) · PubMed · Cited by 35
Zhou, J., Wang, T., Zhao, X., Miller, D. R., & Zhai, S. (2016) · Rheumatology and Therapy · doi:10.1007/s40744-016-0030-6 · Cited by 27
Li, F., Zhou, C., Xu, L., Tao, S., Zhao, J., & Gu, Q. (2016) · PLoS ONE · doi:10.1371/journal.pone.0149400 · Cited by 26
Jang, H., Lim, S., Kim, J., Yoon, S., Lee, C. Y., Hwang, H., Shin, J. W., Shin, K. J., Kim, H. Y., Park, K., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201901437r · Cited by 22
Third-Generation SERMs May Face Uphill Battle
Schmidt, C. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq477 · Cited by 20
Kitaguchi, K., Kashii, M., Ebina, K., Kaito, T., Okada, R., Makino, T., Noguchi, T., Ishimoto, T., Nakano, T., & Yoshikawa, H. (2017) · Bone · doi:10.1016/j.bone.2017.09.021 · Cited by 20
The effect of PPARγ inhibition on bone marrow adipose tissue and bone in C3H/HeJ mice
Beekman, K. M., Veldhuis‐Vlug, A. G., van der Veen, A., den Heijer, M., Maas, M. M., Kerckhofs, G., Parac‐Vogt, T. N., Bisschop, P. H. L. T., & Bravenboer, N. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00265.2018 · Cited by 20
FDA approves first-in-class osteoporosis drug
Mullard, A. (2019) · Nature Reviews Drug Discovery · doi:10.1038/d41573-019-00083-y · Cited by 17
Osteomalacia in a patient with Paget's bone disease treated with long-term etidronate
Hoppé, E., Masson, C., Laffitte, A., Chappard, D., & Audran, M. (2012) · Morphologie · doi:10.1016/j.morpho.2012.08.001 · Cited by 14
Suryadevara, V., Klüppel, M., del Monte, F., & Willis, M. S. (2020) · American Journal Of Pathology · doi:10.1016/j.ajpath.2020.04.013 · Cited by 13
Inhibition of Osteoclastogenesis by Thioredoxin-Interacting Protein-Derived Peptide (TN13)
Kim, M. J., Kim, W. S., Byun, J., Choi, J. H., Yoon, S. R., Choi, I., & Jung, H. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8040431 · Cited by 11
Self-citation
Cited by
Current Status of the Diagnosis and Management of Osteoporosis
Aibar-Almazán, A., Voltes-Martínez, A., Castellote-Caballero, Y., Afanador-Restrepo, D. F., Carcelén-Fraile, M. D. C., & López-Ruiz, E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169465 · Cited by 412
The effect of cytokines on osteoblasts and osteoclasts in bone remodeling in osteoporosis: a review
Xu, J., Yu, L., Liu, F., Wan, L., & Deng, Z. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1222129 · Cited by 263
The Development of Molecular Biology of Osteoporosis
Gao, Y., Patil, S., & Jia, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158182 · Cited by 116
Role and Regulation of Transcription Factors in Osteoclastogenesis
Jiang, T., Xia, T., Qiao, F., Wang, N., Jiang, Y., & Xin, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216175 · Cited by 60
Nrf2 signaling pathway: focus on oxidative stress in osteoporosis
Gu, H.-Y., Liu, N., Lin, F.-X., & Yin, J. (2025) · Osteoporosis International · doi:10.1007/s00198-025-07592-0 · Cited by 10
Metadata
- Authors
- Noh, J.-Y., Yang, Y., & Jung, H.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-10-15
- Volume
- 21
- Issue
- 20
- Pages
- 7623
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W3092959286
- Cited by
- 287
- References
- 186
- FWCI
- 26.31
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.